Facebook
X
LinkedIn
ForwardCharlotte Hematologic Malignancies Congress 2026
This congress will provide an overview of the most recent clinical updates and translational research in myeloid malignancies, lymphoid malignancies, and plasma cell disorders. The program will review the recent approvals in these areas and their implications in treatment planning and management of patient care.
The congress is specifically designed to address common questions community oncologists face including: implementation of T-cell redirecting therapies, infection prevention, and mitigation of adverse events after CAR-T and/or bispecific antibody therapy. Coordination of care between community oncologists and tertiary care centers will be a significant theme of the congress to ensure applicability to all parties.
This program is held in person only.
Target Audience
This course is intended for Physicians, Nurses, Nurse Practitioners, Physician Assistants, Pharmacists and other healthcare professionals.
Learning Objectives
At the end of this session, learners should be able to:
- Integrate novel and newly approved therapies for hematologic malignancies into evidence-based treatment plans.
- Apply appropriate patient selection criteria and sequencing strategies for novel therapies.
- Identify and manage therapy related toxicities, using evidence-based prevention and mitigation strategies.
- Implement coordinated care models between community oncologists and tertiary care centers.
- Evaluate emerging translational research and investigational therapies in hematologic malignancies.
Faculty
- Susan Bal, MD | University of Alabama at Birmingham
- Manish Bhutani, MD | Atrium Health Levine Cancer
- Uma Borate, MD | The Ohio State University
- Madelyn Burkart, MD | Atrium Health Wake Forest Baptist Comprehensive Cancer Center
- Matthew Davids, MD, MMSc | Dana-Farber Cancer Institute, Harvard Medical School
- Andrew Evans, DO, MBA, MSc | Rutgers Robert Wood Johnson Medical School
- Christopher Ferreri, MD | Atrium Health Levine Cancer, Wake Forest University School of Medicine
- Nilanjan Ghosh, MD, PhD | Atrium Health Levine Cancer
- Rebecca Gonzalez, PharmD, BCOP, FASTCT | Moffitt Cancer Center
- Chloe Greguska, PA-C | Atrium Health Levine Cancer
- Mehdi Hamadani, MD | Medical College of Wisconsin
- Marc Hoffmann, MD | University of Kansas Cancer Center
- Sylvester Homsy, MD | Wake Forest University School of Medicine
- Bei Hu, MD | Atrium Health Levine Cancer
- Catherine Lai, MD, MPH | University of Pennsylvania
- Sham Mailankody, MD | Memorial Sloan Kettering Cancer Center
- Alice Mims, MD | The Ohio State
- Tamara Moyo, MD, PhD | Atrium Health Levine Cancer
- Alaa Muslimani, MD | Atrium Health Levine Cancer
- Ajay Nooka, MD | Winship Cancer Institute, Emory
- Robert Orlowski, MD | The University of Texas MD Anderson Cancer Center
- Kwabena Osei-Boateng, MD | Atrium Health Levine Cancer
- Barry Paul, MD, MS | Atrium Health Levine Cancer
- Tycel Phillips, MD, FASCO | City of Hope National Medical Center
- Brittany Ragon, MD | Atrium Health Levine Cancer, Wake Forest Baptist Comprehensive Cancer Center
- Joshua Richter, MD, FACP | Icahn School of Medicine at Mount Sinai
- Jordan Robinson, MMS, PA-C | Atrium Health Levine Cancer
- Lynn Sanders, DSL, MSN | Atrium Health Levine Cancer
- Surbhi Sidana, MD | Stanford University School of Medicine
- Paolo Strati, MD | The University of Texas MD Anderson Cancer Center
- Rakhee Vaidya, MBBS | Atrium Health Wake Forest
- Cindy Varga, MD | Atrium Health Levine Cancer
- Kelly Weaver, DNP, APRN, NP-C, ACNS-BC, OCN, AOCNP | Atrium Health Levine Cancer
- Matthew Wieduwilt, MD, PhD | Wake Forest University School of Medicine
- Alex Wolff, PharmD, BCOP, FHOPA | Atrium Health Levine Cancer
- Amer Zeidan, MBBS, MHS | Yale Comprehensive Cancer Center and Smilow Cancer Hospital
- Joshua Zeidner, MD | University of North Carolina, Lineberger Comprehensive Cancer Center
Disclosure
Faculty disclosures are being reviewed and will be presented to the audience in advance of the program.
Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Statement(s)
American Medical Association (AMA)
Advocate Health designates this live activity for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Advocate Health designates this live activity for a maximum of 8.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of Physician Associates (AAPA)
Advocate Health has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Accreditation Council for Pharmacy Education (ACPE)
Advocate Health designates this live activity for a maximum 8.50 hours of CPE credit for (pharmacists and pharmacy technicians). CPE credit can be claimed on the AAH CE platform within 60 days of activity completion and information will be provided to CPE Monitor. Participants should only claim credit commensurate with the extent of their participation in the activity.
Pharmacy UAN: JA0006327-0000-26-117-L01-P
Board Recognition Statement(s)
American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Available Credit
- 8.50 American Board of SurgerySuccessful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
- 8.50 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 8.50 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 8.50 AttendanceAttendance Credit
- 8.50 Approved AMA PRA Category 1 Credit™
- 8.50 Continuing Nursing Education (CE)Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 8.50 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
- 8.50 Continuing Pharmacy Education (CPE)Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 8.50 Physician Associates CreditAdvocate Health has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Price
How to Register
Complete the form above and click "Add to cart."
Click "Checkout" and follow the prompts to complete your order.
| FEE | |
Industry registration fee | $300.00 |
| Practicing healthcare providers registration fee | $ 0.00 |
Payable by credit card only
Cancellation and Refund Policy
Cancellation/Refunds/Substitutions
- Cancellations must be in writing (email)
- Registrants cancelling between two weeks and five full business days prior to the first day of the event are "refunded at 70% of the registration fee subject to a minimum $25 cancellation fee."
- No refunds or credits will be given for cancellations received less than five full business days prior to the event.
- No refunds or credit will be given for no-shows.
- No vouchers will be issued in lieu of a refund.
For Further Information
If you have any questions regarding the conference, please contact [email protected]
Please take some time to view your profile to make sure all required fields are up to date.